Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss (Q90596734)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30559422%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

title

Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30559422%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30559422%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

author name string

Huayang Liu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30559422%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Javad Golji

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30559422%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Lauren K Brodeur

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30559422%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Franklin S Chung

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30559422%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Julie T Chen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30559422%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Rosalie S deBeaumont

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30559422%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Caroline P Bullock

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30559422%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Michael D Jones

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30559422%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Grainne Kerr

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30559422%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Li Li

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30559422%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Daniel P Rakiec

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30559422%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Michael R Schlabach

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30559422%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Sosathya Sovath

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30559422%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Joseph D Growney

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30559422%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Raymond A Pagliarini

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30559422%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

David A Ruddy

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30559422%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Kenzie D MacIsaac

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30559422%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Joshua M Korn

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30559422%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

publication date

17 December 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30559422%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30559422%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30559422%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30559422%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

page(s)

95-102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30559422%20AND%20SRC:MED&resulttype=core&format=json

Interferons, immunity and cancer immunoediting

14 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

Type I interferons in infectious disease

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

Antitumour actions of interferons: implications for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

Type I interferons in anticancer immunity

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

Tumor interferon signaling regulates a multigenic resistance program to immune checkpoint blockade

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

Mechanisms of type-I- and type-II-interferon-mediated signalling

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

Regulation of type I interferon responses

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

Systematic pan-cancer analysis of tumour purity

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

Inferring tumour purity and stromal and immune cell admixture from expression data

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

Interferon-γ: an overview of signals, mechanisms and functions

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

Molecular and genetic properties of tumors associated with local immune cytolytic activity

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

5-(1H-Benzimidazol-1-yl)-3-alkoxy-2-thiophenecarbonitriles as potent, selective, inhibitors of IKK-epsilon kinase

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

The RNA-editing enzyme ADAR1 controls innate immune responses to RNA.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

Isoforms of RNA-Editing Enzyme ADAR1 Independently Control Nucleic Acid Sensor MDA5-Driven Autoimmunity and Multi-organ Development.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

Interferon-inducible antiviral effectors

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

The integrated stress response.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

Protein kinase PKR and RNA adenosine deaminase ADAR1: new roles for old players as modulators of the interferon response

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

Inhibition of the inflammatory response to stress by targeting interaction between PKR and its cellular activator PACT.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

Double-stranded RNA-activated protein kinase mediates induction of interleukin-8 expression by deoxynivalenol, Shiga toxin 1, and ricin in monocytes

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

DNA damage primes the type I interferon system via the cytosolic DNA sensor STING to promote anti-microbial innate immunity

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

DNA-damage-induced type I interferon promotes senescence and inhibits stem cell function

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

Mitotic progression following DNA damage enables pattern recognition within micronuclei.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

cGAS surveillance of micronuclei links genome instability to innate immunity

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

Apoptotic caspases prevent the induction of type I interferons by mitochondrial DNA.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

The Molecular Signatures Database (MSigDB) hallmark gene set collection

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

Parsing the Interferon Transcriptional Network and Its Disease Associations

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic Regions

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

limma powers differential expression analyses for RNA-sequencing and microarray studies

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

Unbiased Recursive Partitioning: A Conditional Inference Framework

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

A scaling normalization method for differential expression analysis of RNA-seq data

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

Moderated statistical tests for assessing differences in tag abundance

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

A probability-based approach for the analysis of large-scale RNAi screens.

1 reference

https://api.crossref.org/works/10.1038%2FS41591-018-0302-5

7 January 2021

10.1038/S41591-018-0302-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30559422%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

1 reference